Outpatient Management of Meniere's Disease
The first-line outpatient treatment for Meniere's disease includes vestibular suppressants for acute attacks, lifestyle modifications (particularly sodium restriction), and maintenance therapy with diuretics and/or betahistine. 1, 2
Acute Attack Management
- Vestibular suppressants should be offered as first-line therapy for acute vertigo attacks 2:
- Benzodiazepines (e.g., alprazolam)
- Antiemetics
- Caution: Risk of dependence, sedation, and impaired vestibular compensation 1
- Use for shortest duration necessary to control symptoms
Lifestyle and Dietary Modifications
Additional dietary modifications:
Cooling measures for symptom relief:
Maintenance Pharmacotherapy
Diuretics may be offered to reduce endolymph volume 1, 2:
- Thiazides (e.g., hydrochlorothiazide)
- Potassium-sparing diuretics
- Loop diuretics
- Note: Consider as second-line therapy after vestibular suppressants 2
Procedural Interventions (for refractory cases)
Intratympanic steroid injections for persistent symptoms despite medical management 2
Intratympanic gentamicin may be considered for vertigo control in refractory cases 2
- Caution: Risk of hearing loss
Surgical options for severe refractory cases:
Rehabilitation and Support
Vestibular rehabilitation (physical therapy) for chronic imbalance between attacks 2
Hearing aids for patients with hearing loss 2
Patient education about:
Important Considerations
Do NOT prescribe positive pressure therapy (e.g., Meniett device) as evidence shows ineffectiveness 1
Monitor disease progression with:
- Regular audiologic assessment
- Documentation of vertigo frequency and severity
- Quality of life assessment 2
Rule out vestibular migraine as it can coexist with or mimic Meniere's disease 2
Consider multidisciplinary approach for patients with severe, refractory, or disabling symptoms 1
The management of Meniere's disease should focus on controlling acute attacks while implementing strategies to reduce the frequency and severity of future episodes. While many treatments are recommended based on clinical experience rather than high-quality evidence, a structured approach using vestibular suppressants for acute attacks and lifestyle modifications with maintenance medications for prevention represents the current standard of care.